Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays.

Rapid Commun Mass Spectrom

Global Pharmaceutical Research and Development, Abbott Laboratories, Advanced Technologies, Dept. R4CP, Bldg. AP52-N, 200 Abbott Park Road, Abbott Park, IL 60064-6217, USA.

Published: March 2005

High-throughput metabolic screening has been requested routinely to keep pace with high-throughput organic synthesis. Liquid chromatography/tandem mass spectrometry (LC/MS/MS) with a fast gradient has become the method of choice for the task due to its sensitivity and selectivity. We have developed an automated system that consists of a robotic system for in vitro incubation and a commercially available software package for automatic MS/MS method development. A short, generic LC gradient and MS conditions that are applicable to most compounds have been developed to minimize the method development time and data analysis. This system has been used to support a number of in vitro screening assays in early drug discovery phase including microsomal stability and protein binding.

Download full-text PDF

Source
http://dx.doi.org/10.1002/rcm.1735DOI Listing

Publication Analysis

Top Keywords

method development
12
mass spectrometry
8
drug discovery
8
automatic mass
4
method
4
spectrometry method
4
development drug
4
discovery application
4
application metabolic
4
metabolic stability
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!